Clinical Trials Logo

Analgesia, Obstetrical clinical trials

View clinical trials related to Analgesia, Obstetrical.

Filter by:

NCT ID: NCT02578251 Not yet recruiting - Clinical trials for Analgesia, Obstetrical

Paracetamol for Intrapartum Analgesia

Start date: October 2015
Phase: Phase 2
Study type: Interventional

The aim of this study is to assess whether paracetamol is as effective as pethidine for analgesia during the first stage of labor.

NCT ID: NCT02557087 Not yet recruiting - Clinical trials for Analgesia, Obstetrical

Hyoscine ButylBromide for Intrapartum Analgesia

Start date: September 2015
Phase: Phase 2
Study type: Interventional

The aim of this study is to assess whether hyoscine butylbromide is as effective as pethidine for analgesia during the first stage of labor.

NCT ID: NCT02509312 Completed - Postoperative Pain Clinical Trials

Prospective Effect of Intravenous Ketorolac on Opioid Use, EBL and Complications Following Cesarean Delivery

Start date: May 2016
Phase: Phase 4
Study type: Interventional

In this randomized, double-blind control trial to evaluate the effect of ketorolac given at the time of cord clamp has on estimated blood loss and postcesarean pain control. Patients will be randomized to either placebo or ketorolac prior to surgery. Those randomized to ketorolac will receive ketorolac at cord clamp and three additional doses every 6 hours (total 4 doses/24 hours). Those in the placebo group will receive normal saline during those time periods. Our primary outcome is to assess whether intra-operative ketorolac increases the estimated blood loss during Cesarean delivery.

NCT ID: NCT02009722 Completed - Cesarean Section Clinical Trials

Intrathecal Opioids for Pain Control After Cesarean Delivery: Determining the Optimal Dose

Start date: January 2014
Phase: Phase 4
Study type: Interventional

Both hydromorphone and morphine are administered as part of spinal anesthesia to help improve pain control after cesarean delivery. In this study, the investigators are going to determine the doses of each of those medicines that provides optimal pain control to women undergoing cesarean delivery while limiting side effects related to those medicines. The investigators hypothesize that the doses of hydromorphone and morphine that provide optimal pain control without significant side effects will be 100 micrograms and 150 micrograms, respectively. The investigators further hypothesize that at each respective optimal dose, side effects will be less in the hydromorphone group.